Beyond Angioplasty: How CT Scans Are Revolutionizing Stent Monitoring
"Discover how CT perfusion imaging enhances accuracy in detecting in-stent restenosis, offering hope for improved cardiac care and reduced radiation exposure."
Coronary artery disease (CAD) remains a leading cause of morbidity and mortality worldwide. Percutaneous coronary intervention (PCI), involving the placement of stents to open blocked arteries, has become a standard treatment. However, a significant challenge arises with in-stent restenosis (ISR), where the stented artery narrows again, leading to recurrent symptoms and the need for further intervention.
Traditional methods for detecting ISR, such as coronary angiography, are invasive and carry risks. Coronary CT angiography (CCTA) has emerged as a non-invasive alternative, but its accuracy in stented vessels can be limited. This is where CT perfusion (CTP) imaging steps in, offering a functional assessment of blood flow to the heart muscle.
The ADVANTAGE study, a groundbreaking investigation, explores the combined power of CCTA and CTP in diagnosing ISR. This article delves into the study's findings, highlighting how CTP enhances diagnostic accuracy, improves patient outcomes, and minimizes radiation exposure, marking a significant leap forward in cardiac care.
Persistent Risk of Restenosis
The JACC state-of-the-art review reports that in-stent restenosis (ISR), and the resulting need for repeat revascularization, still occur at a rate of 1%–2% per year despite improvements in percutaneous coronary intervention from drug-eluting stent technologies. The ADVANTAGE study examined whether CT perfusion adds diagnostic value over coronary CT angiography in stented patients suspected of ISR or coronary artery disease progression; the supplied source identifies its results as preliminary. A 2025 real-world study likewise set out to evaluate coronary CT angiography for detecting ISR and identify stent-related factors, but the supplied description does not report its findings.
CT Assessment and Its Constraints
Coronary CT angiography (CCTA) is used to assess coronary stents, but its ability to detect restenosis can be limited by difficulty accurately discerning the lumen. A study of 35 consecutive subjects evaluated dual-source CT for stent patency and restenosis, investigating whether its temporal resolution could improve stent visualization without heart-rate control. A 2024 meta-analysis was designed to compare CCTA alone with CCTA combined with CT perfusion (CTP) for detecting angiography-defined ISR; the supplied description does not provide its results.
Defining Restenosis After PCI
A review of in-stent restenosis describes restenosis as a reduction in lumen diameter after percutaneous coronary intervention (PCI), whether or not a stent was implanted. The review situates this concept alongside bare-metal stents, drug-eluting stents, drug-coated balloons, and paclitaxel-eluting balloons. The supplied source excerpt provides this definition and terminology, but does not specify a chronology of milestones or dates.
The ADVANTAGE Study: Unveiling the Power of Combined Imaging
The ADVANTAGE study aimed to evaluate the diagnostic performance of CCTA alone, CTP alone, and the combination of CCTA and CTP in patients suspected of having ISR or progression of native CAD. Conducted with the latest scanner generation, which provides whole-heart coverage with high spatial and temporal resolution, the study used invasive coronary angiography (ICA) as the gold standard for comparison.
- Feasibility Boost: CTP proved significantly more feasible than CCTA in stent-based, territory-based, and patient-based analyses.
- Enhanced Accuracy: CTP alone demonstrated higher diagnostic accuracy than CCTA alone in detecting ISR.
- Synergistic Effect: The combined CCTA-CTP evaluation further improved diagnostic accuracy, especially when CCTA and CTP findings were concordant.
- Radiation Conscious: The mean effective dose for the entire CT assessment (CCTA-CTP) was a relatively low 2.76 ± 2.32 mSv.
New Imaging and Treatment Directions
A June 2026 report on photon-counting detector CT (PCD-CT) says it could improve confidence in confirming or excluding ISR on noninvasive imaging in symptomatic patients after PCI. A 2026 review focuses on the pathophysiological mechanisms of in-stent calcification restenosis, while another review describes ISR as a continuing cause of recurrent ischemia and repeat revascularization despite refinements in stents and implantation technique. A 2025 treatment review reports similar effectiveness for paclitaxel drug-coated balloons and second-generation drug-eluting stents; it describes sirolimus-coated balloons as an emerging technology needing further investigation.
The ADVANTAGE Study Design
The supplied source describes the ADVANTAGE study as examining CT perfusion versus coronary CT angiography in patients with suspected in-stent restenosis or coronary artery disease progression. It notes that the study design had been described previously. The excerpt provides no results or evidence of diagnostic failure, so it does not establish whether adding CT perfusion improved detection.
Comparing Combined CT Approaches
A November 2024 study compared combined coronary CTA, CT perfusion (CTP), and CT-derived fractional flow reserve (CT-FFR) with coronary CTA alone. Separately, a meta-analysis published in March 2025 was designed to assess CCTA alone against CCTA plus CTP for angiography-defined in-stent restenosis. The supplied descriptions establish the approaches being compared but do not provide comparative performance results, so they do not support a conclusion that one approach is more accurate.
A New Era in Stent Monitoring
The ADVANTAGE study underscores the potential of CTP as a valuable tool in assessing patients with suspected ISR. Its enhanced feasibility, accuracy, and ability to provide functional information about myocardial perfusion make it a promising addition to the diagnostic armamentarium. The study's findings suggest that CTP, particularly when combined with CCTA, can lead to more accurate diagnoses, improved patient management, and reduced radiation exposure. As technology advances, we can expect even more refined imaging techniques to further optimize the care of patients with coronary artery disease.
Uncharacterized Plaque-Modification Trends
A September 2026 report examines national trends and in-hospital outcomes for ISR percutaneous coronary interventions treated with adjunctive plaque-modification strategies. Its source description says contemporary adoption patterns and outcomes of these strategies are incompletely characterized. The excerpt does not provide the study’s findings, so the scale or effects of these trends cannot be specified from the available material.
ISR Remains a Clinical Challenge
A 2026 review describes in-stent restenosis as a common challenge in catheterization laboratories worldwide despite advances in PCI techniques and stent technology. Another source reports that restenosis-related target lesion revascularization has declined from bare-metal stents to early- and newer-generation drug-eluting stents, while ISR remains a clinically relevant cause of recurrent ischemia and repeat revascularization. Together, these sources indicate improvement over time alongside an ongoing clinical burden.
Imaging and Repeat Intervention in a Case
A case study from Manchester Royal Infirmary reports that quantitative myocardial blood-flow data helped guide initial stent placements. After the patient later developed stent occlusion, a follow-up PET/CT using Siemens Healthineers’ technology identified a new site of restenosis, leading to a second intervention. Separately, a 2019 report identifies the challenge of detecting ISR with CCTA and notes that adenosine-stress CT myocardial perfusion had demonstrated additional diagnostic power over CCTA in patients with unknown coronary artery disease; the supplied excerpt does not provide further outcome details.